|
|
| Attention Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Your results on : Equity | Company Profile | Detailed Quotes |
|
|
|
|
|
|
|
|
|
|
|
| Stock Price Details |
|
Chart |
|
| Last Price |
42.35 |
|
| Change |
0.25 (0.59%) |
|
| Best Buy |
42.05(x60) |
|
| Best Sell |
42.32(x300) |
|
| Today's Range |
41.83
- 43.55 |
|
| 52-Week Range |
25.35
- 65.85 |
|
|
|
1 Day
| 5 Day
| 3 Month
| 1 Year
| 5 Year
|
|
|
|
| News |
|
Corporate Details |
|
|
|
| Incorporation Year : 2016 |
|
| Chairman : Dilip V Acharekar |
|
| Ownership Group : Indian Private |
|
| Sector : MAN |
|
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Registered Office |
|
Vineet Laboratories Ltd SyNo 11/A3 Saheb Nagar KurduVi, Chintal Kunta Eshwaramma LB Nr, , Telangana-500074 |
|
Phone:91-40-24128833 Fax: |
|
| E-Mail : cs@vineetlabs.co.in |
|
| URL : http://www.vineetlabs.co.in |
|
|
|
| Investor Returns |
|
| |
|
Date |
|
Price (Rs) |
|
Returns (%) |
|
|
| 1Week |
12-Dec-2025 |
43.23 |
-2.61 |
|
| 1Month |
19-Nov-2025 |
42.00 |
0.24 |
|
| 3Month |
19-Sep-2025 |
34.50 |
22.03 |
|
| 6Month |
19-Jun-2025 |
28.92 |
45.57 |
|
| 1Year |
19-Dec-2024 |
58.92 |
-28.55 |
|
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
|
Last Price(Rs) |
|
Change(%) |
|
52Week High(Rs) |
|
52Week Low(Rs) |
|
Market Cap(Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,756.75 |
0.67 |
1,910.00 |
1,547.25 |
4,18,707.95 |
|
| Cipla Ltd |
1,522.40 |
0.36 |
1,672.20 |
1,310.05 |
1,22,538.89 |
|
| Dr Reddys Laboratories Ltd |
1,281.55 |
0.21 |
1,404.60 |
1,025.90 |
1,06,740.88 |
|
| Lupin Ltd |
2,128.00 |
0.11 |
2,403.45 |
1,774.00 |
97,101.72 |
|
| Zydus Lifesciences Ltd |
922.25 |
0.26 |
1,059.00 |
797.05 |
92,558.43 |
|
|
|
|
|
|
|
| |
|
|
| |
| X |
| Filing complaints on SCORES |
| Easy & Quick |
| |
| › |
Register on SCORES Portal |
› |
Mandatory details for filing complaints on SCORES
| Name |
PAN |
Address |
Mobile No. |
Email ID |
|
| › |
Benefits: |
| |
|
|
|